对于癌症治疗的Geranylgeranyl二酸盐合成酶 (GGDPS) 的结构洞察力
Andrew C Pham1, Sarah A Holstein2, Gloria E O Borgstahl1,3
1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska.
Molecular cancer therapeutics
|September 27, 2023
概括
格拉尼尔格拉尼尔二酸合成酶 (GGDPS) 是癌症药物的关键标. 本综述详细介绍了GGDPS的结构和相互作用,以帮助开发更有效的抗癌疗法.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 药用化学 医学化学
背景情况:
- 基拉尼尔基拉尼尔二酸合成酶 (GGDPS) 对于蛋白质基拉尼尔基拉尼化至关重要,这是癌细胞生存至关重要的过程.
- 癌症的依赖于基拉尼尔基拉尼蛋白使得GGDPS成为抗癌药物开发的有吸引力的目标.
- 目前的抑制剂,主要是含双酸盐,需要优化以改善药物向相互作用.
研究的目的:
- 为GGDPS提供全面的,以结构为重点的审查.
- 为了阐明GGDPS结构,活性部位和配体/产物相互作用.
- 促进基于结构的药物设计,以改善GGDPS抑制剂.
主要方法:
- 现有的酵母和人类GGDPS晶体结构的审查.
- 通过AlphaFold建模来完成和完善结构模型.
- 分析高阶结构,基质/连接体结合和静电表面.
主要成果:
- 详细划分GGDPS更高层次的结构元素.
- 产品基质结合部位和机制的表征.
- 小分子抑制剂结合口袋和相互作用的映射.
结论:
- 了解GGDPS结构,活性部位和连接体相互作用对于推进抑制剂开发至关重要.
- 提出的综合结构见解将促进抑制剂选择性和有效性的合理优化.
- 本综述是基于结构的药物设计的宝贵资源,用于针对癌症治疗中的GGDPS.
更多相关视频
13:51Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
9.9K
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
12.3K
相关概念视频
G Protein-coupled Receptors
12.2K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.2K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
